Obesema 0.5mg Injection
Available Pack Sizes
Free Shipping
Order above $200.00
Worldwide Delivery
8-10 Business Days
24/7 Support
Solve your queries
- 100% Genuine Medicines
- Secure International Logistics
- Secure Payment
- Authentic Pharmaceutical Supplier
How to Order from Medionix Pharma
Add Products
Browse our medicines and add the required products to your cart.
Add Products to Cart
Order Method
Place your order easily through WhatsApp or Email support.
Choose Your Ordering Method
Share Details
Provide your delivery address and contact information.
Share Delivery & Prescription Details
Order Dispatched
Your order is packed securely and shipped worldwide.
Order Confirmation & Dispatch
Obesema 0.5mg Injection
contains Semaglutide 0.5mg per weekly dose in a pre-filled pen, manufactured by Abbott. This is the first therapeutic maintenance dose in the Obesema range, delivering meaningful glycaemic improvement and progressive weight reduction in adults with type 2 diabetes or overweight/obesity. Abbott ensures pharmaceutical-grade manufacturing quality.
Benefits:
- Clinically meaningful HbA1c reduction (~1.4%) and 3–4% body weight loss at maintenance
- Excellent gastrointestinal tolerability in most patients transitioning from the 0.25mg initiation dose
- Once-weekly injection schedule with maximum convenience
- Established cardiovascular benefit data from the SUSTAIN trial programme
- Affordable first therapeutic maintenance dose by Abbott
How It Works:
At 0.5mg, semaglutide achieves robust GLP-1 receptor activation — reducing caloric intake through central appetite suppression, delaying gastric emptying to extend satiety, and amplifying glucose-dependent insulin release. These mechanisms combine to reduce both fasting and post-meal blood glucose levels while promoting progressive, sustained weight loss.
Dosage and Administration:
Inject 0.5mg subcutaneously once weekly after completing at least 4 weeks on the 0.25mg dose. Administer into the abdomen, thigh, or outer upper arm. Rotate injection sites. For enhanced weight loss, your prescriber may advance to the 1mg dose after at least 4 weeks.
Side Effects:
Common: nausea, diarrhoea, vomiting, constipation, abdominal pain. Uncommon: fatigue, hypoglycaemia (if combined with insulin or sulphonylurea). Serious: pancreatitis, gallbladder disease.
Precautions:
Contraindicated in personal or family history of medullary thyroid carcinoma or MEN2. Reduce concurrent insulin/sulphonylurea doses as needed. Not recommended during pregnancy.
Obesema Dosage Comparison Guide
| Strength | Best For | Onset | Duration | Link |
|---|---|---|---|---|
| 0.25mg | Lower strength option | 2–4 wks | Weekly | View → |
| 0.5mg | Standard strength option | 2–4 wks | Weekly | Current |
| 1mg | Popular strength option | 2–4 wks | Weekly | View → |
| 1.7mg | Higher strength option | 2–4 wks | Weekly | View → |
| 2.4mg | Maximum strength variant | 2–4 wks | Weekly | View → |
* Always consult your doctor before changing your dosage. This information is for educational reference only.
Frequently Asked Questions
Q1: What is Obesema 0.5mg used for?
Obesema 0.5mg is the first therapeutic maintenance dose of injectable semaglutide by Abbott, prescribed for adults with type 2 diabetes for glycaemic control and weight management after completing the 4-week 0.25mg initiation phase.
Q2: How much weight can I lose on Obesema 0.5mg?
Clinical data for semaglutide 0.5mg shows approximately 3–4% body weight reduction over 30 weeks in patients with type 2 diabetes. Greater weight loss is typically achieved at higher doses.
Q3: Can Obesema 0.5mg be a long-term maintenance dose?
Yes. The 0.5mg dose is a licensed maintenance dose for type 2 diabetes and can be continued long term if it provides adequate glycaemic and weight management. Some patients are advanced to 1mg for greater effect.
Q4: Does Obesema 0.5mg require refrigeration?
Unopened pens must be refrigerated at 2–8°C. Once in use, the pen can be kept at room temperature below 30°C for up to 56 days — making weekly travel-friendly dosing straightforward.
Q5: Is Obesema 0.5mg suitable if I have both diabetes and obesity?
Yes. Semaglutide 0.5mg provides both glycaemic benefit for type 2 diabetes and meaningful weight reduction, making it an excellent option for patients with both conditions.
Customer Reviews
Dr. Emily Parker
UK · 2 months ago
“Impressed with the professionalism. Certificate of Analysis provided on request. Will be placing repeat orders for our clinic.”
Metro Hospital Pharmacy
UK · 2 weeks ago
“Reliable supplier. Product met all our quality standards. Great communication throughout the entire procurement process.”
Global Meds Supply
Germany · 6 weeks ago
“Ordering from Medionix for several months now. Consistent pharmaceutical quality and professional service every time.”
Thomas B.
Australia · 4 months ago
“Legitimate pharmaceutical supplier. Packaging intact, expiry dates clearly printed, batch numbers traceable. Very satisfied.”
Robert Chen
Canada · 1 month ago
“Very satisfied with the order. Packaging was secure and delivery was on time. Quality matches the description perfectly.”
Related Products
Disclaimer
The information provided on Medionix Pharma is intended for general informational purposes only. It should not be considered as medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional before using any medication or starting any treatment.
Medionix Pharma does not encourage self-medication. Customers are responsible for ensuring that purchases comply with local laws and prescription requirements in their country. If you have any questions or concerns regarding the content on our website, please contact us at sales@medionixpharma.com.